Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument
American Journal of Clinical Pathology · 2024
DOI: 10.1093/ajcp/aqae040 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2024. Verfasst von Darci R Block und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, US. Hauptthemen laut MEDLINE: Hemolysis, Hyperlipidemias, Jaundice. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objectives
The aims of this study were to (1) establish the maximum allowable interference limits for hemolysis, lipemia, and icterus for chemistry analytes tested in body fluid samples and (2) assess the effectiveness of serial dilution to mitigate spectral interferences.
Methods
Residual body fluids from clinically ordered testing were mixed (<10% by volume) with stock solutions of interferent (spiked) and compared with a control spiked with an equal volume of 0.9% saline. The analytes were measured on the Roche cobas c501 instrument. Difference and percentage difference were calculated and compared with allowable total error limits. A subset of samples were serially diluted with 0.9% saline. Mean (SD) difference and percentage difference were calculated.
Results
The interference thresholds were lower than the package insert for lactate dehydrogenase, cholesterol, triglycerides, and total protein for hemolysis; amylase, cholesterol, and total protein for icterus; and albumin for lipemia. Only cholesterol and triglyceride results returned to baseline upon dilution of icteric samples.
Conclusions
Interference thresholds in body fluids were lower than blood for 6 analytes. Diluting interferences that surpass these limits does not produce reliable results that are comparable to the baseline results before spiking in the interferent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, US.
ORCID-Profile: Darci R Block
Zitieren
APA
Block, D. R., Lasho, M. A., Donato, L. J., & Meeusen, J. W. (2024). Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqae040
Vancouver
Block DR, Lasho MA, Donato LJ, Meeusen JW. Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument. American Journal of Clinical Pathology. 2024. doi:10.1093/ajcp/aqae040
BibTeX
@article{Block2024,
author = {Block, Darci R and Lasho, Michael A and Donato, Leslie J and Meeusen, Jeffrey W},
title = {Establishing hemolysis, icterus, and lipemia interference limits for body fluid chemistry analytes measured on the Roche cobas instrument},
journal = {American Journal of Clinical Pathology},
year = {2024},
doi = {10.1093/ajcp/aqae040}
}
EUVIMED